Literature DB >> 30386876

Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.

Maria Stefania De Simone1, Roberta Perri2, Lucia Fadda2,3, Carlo Caltagirone2,3, Giovanni Augusto Carlesimo2,3.   

Abstract

The research of reliable procedures for predicting cognitive decline or stability in persons with amnestic mild cognitive impairment (a-MCI) is a major goal for the early identification of subjects in the prodromal stages of dementia. The aim of this study was to evaluate whether different memory performances on two procedures commonly used for the neuropsychological assessment of episodic memory (i.e., free recall and recognition) might be a key in predicting a-MCI patients' subsequent progression to Alzheimer's disease (AD). For this purpose, 80 patients diagnosed with a-MCI at the first assessment and followed-up for at least 3 years were included. During this time, 41 subjects remained in a stable condition of cognitive impairment or improved (stable-MCI) and 39 patients converted to AD dementia (converter-MCI). Sixty-two age- and education-matched healthy individuals were also recruited as healthy controls (HC). Baseline memory performance on the free recall (5th immediate and 15-min delayed) and yes/no recognition (the sensitivity measure d') of a 15-word list were analyzed. Results showed that stable-MCIs forgot significantly more information from immediate to delayed recall of the word list than HC, but exhibited a pronounced improvement of memory performance in the recognition test format. On the contrary, converter-MCIs showed diminished sensitivity in benefiting from cues for recognizing studied words. Word list recognition correctly classified group membership with good overall accuracy, which was higher compared to the classification of converter and stable a-MCIs provided by free recall; therefore, it could be a useful diagnostic tool for predicting progression to AD dementia from the prodromal stage.

Entities:  

Keywords:  Alzheimer’s disease; Conversion; Memory tests; Mild cognitive impairment

Mesh:

Year:  2018        PMID: 30386876     DOI: 10.1007/s00415-018-9108-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  45 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

Review 2.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

3.  Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population.

Authors:  Marco Monaco; Alberto Costa; Carlo Caltagirone; Giovanni Augusto Carlesimo
Journal:  Neurol Sci       Date:  2012-06-12       Impact factor: 3.307

4.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Authors:  Liana G Apostolova; Rebecca A Dutton; Ivo D Dinov; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson
Journal:  Arch Neurol       Date:  2006-05

5.  Mild cognitive impairment: a concept in evolution.

Authors:  R C Petersen; B Caracciolo; C Brayne; S Gauthier; V Jelic; L Fratiglioni
Journal:  J Intern Med       Date:  2014-03       Impact factor: 8.989

6.  Memory evaluation in mild cognitive impairment using recall and recognition tests.

Authors:  Ilana J Bennett; Edward J Golob; Elizabeth S Parker; Arnold Starr
Journal:  J Clin Exp Neuropsychol       Date:  2006-11       Impact factor: 2.475

7.  Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment.

Authors:  Sara García-Herranz; M Carmen Díaz-Mardomingo; Herminia Peraita
Journal:  J Neuropsychol       Date:  2015-03-23       Impact factor: 2.864

8.  Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease.

Authors:  Guila Glosser; Jennifer L Gallo; Christopher M Clark; Murray Grossman
Journal:  Neuropsychology       Date:  2002-04       Impact factor: 3.295

9.  Aging, recall and recognition: a study on the sensitivity of the University of Southern California Repeatable Episodic Memory Test (USC-REMT).

Authors:  Elizabeth S Parker; Susan M Landau; Stephen C Whipple; Barbara L Schwartz
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

10.  When the amnestic mild cognitive impairment disappears: characterisation of the memory profile.

Authors:  Roberta Perri; Giovanni A Carlesimo; Laura Serra; Carlo Caltagirone
Journal:  Cogn Behav Neurol       Date:  2009-06       Impact factor: 1.600

View more
  13 in total

1.  A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  María Eugenia López; Agustín Turrero; Pablo Cuesta; Inmaculada Concepción Rodríguez-Rojo; Ana Barabash; Alberto Marcos; Fernando Maestú; Alberto Fernández
Journal:  Geroscience       Date:  2020-09-04       Impact factor: 7.713

2.  Lost or unavailable? Exploring mechanisms that affect retrograde memory in mild cognitive impairment and Alzheimer's disease patients.

Authors:  Maria Stefania De Simone; Massimo De Tollis; Lucia Fadda; Roberta Perri; Carlo Caltagirone; Giovanni Augusto Carlesimo
Journal:  J Neurol       Date:  2019-09-30       Impact factor: 4.849

3.  Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Min Young Chun; Geon Ha Kim; Hee Kyung Park; Dong Won Yang; SangYun Kim; Seong Hye Choi; Jee Hyang Jeong
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

4.  Harnessing forgetfulness: can episodic-memory tests predict early Alzheimer's disease?

Authors:  Samuel L Warren; Ahmed A Moustafa; Hany Alashwal
Journal:  Exp Brain Res       Date:  2021-07-27       Impact factor: 1.972

5.  Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers.

Authors:  Yu Sun; Xiaoni Wang; Yinshan Wang; Haoming Dong; Jie Lu; Tohar Scheininger; Michael Ewers; Frank Jessen; Xi-Nian Zuo; Ying Han
Journal:  Alzheimers Res Ther       Date:  2019-06-03       Impact factor: 6.982

6.  Electronic Cognitive Screen Technology for Screening Older Adults With Dementia and Mild Cognitive Impairment in a Community Setting: Development and Validation Study.

Authors:  Joyce Y C Chan; Adrian Wong; Brian Yiu; Hazel Mok; Patti Lam; Pauline Kwan; Amany Chan; Vincent C T Mok; Kelvin K F Tsoi; Timothy C Y Kwok
Journal:  J Med Internet Res       Date:  2020-12-18       Impact factor: 5.428

7.  Effects of white matter hyperintensities distribution and clustering on late-life cognitive impairment.

Authors:  Joan Jiménez-Balado; Fabian Corlier; Christian Habeck; Yaakov Stern; Teal Eich
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

8.  Optimizing Cognitive Assessment Outcome Measures for Alzheimer's Disease by Matching Wordlist Memory Test Features to Scoring Methodology.

Authors:  Jason R Bock; Julie Russell; Junko Hara; Dennis Fortier
Journal:  Front Digit Health       Date:  2021-11-03

9.  The role of metamemory on cognitive complaints in cancer patients.

Authors:  Bénédicte Giffard; Audrey Perrotin; Philippe Allain; Jacques Dayan; Francis Eustache; Jean-Michel Grellard; Audrey Faveyrial; Florence Joly; Marie Lange
Journal:  Brain Behav       Date:  2020-03-10       Impact factor: 2.708

10.  Prevalence, Incidence, Influence Factors, and Cognitive Characteristics of Amnestic Mild Cognitive Impairment Among Older Adult: A 1-Year Follow-Up Study in China.

Authors:  Wei Li; Lin Sun; Shifu Xiao
Journal:  Front Psychiatry       Date:  2020-02-28       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.